Skip to main content
Log in

Therapy with gastrin antibody in the Zollinger-Ellison syndrome

  • Original Articles
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Abstract

The therapeutic effectiveness of parenterally administered rabbit antigastrin antibody was evaluated in a patient with the Zollinger-Ellison syndrome who had a fasting serum gastrin level of 3020 pg/ml and a basal gastric acid secretion of 48.9 mEq/hr. Control globulin reduced gastric secretion to 32 mEq/hr. Gastrin antibody reduced it further to 8.7 mEq/hr. Betazole hydrochloride which was given 75 min after administration of gastrin antibody stimulated acid secretion to 57.2 mEq/hr. One day later basal acid secretion was uninhibited although some antibody activity was present in the patient's serum. The results suggested that gastrin antibody acutely inhibited basal but not betazole-stimulated secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jaffe BM, Newton WT, McGuigan JE: Inhibition of gastrin activity by incubation with antibodies to the C-terminal tetrapeptide of gastrin. Surgery 65:633–639, 1969

    PubMed  Google Scholar 

  2. Jaffe BM, Newton WT, McGuigan JE: Inhibition of endogenous gastrin activity by antibodies to the carboxy-terminal tetrapeptide amide of gastrin. Gastroenterology 58:151–156, 1970

    PubMed  Google Scholar 

  3. Jaffe BM, McGuigan JE, Newton WT: Gastrin resistance following immunization to the C-terminal tetrapeptide amide of gastrin. Surgery 69:232–237, 1971

    PubMed  Google Scholar 

  4. Lipshutz W, Hughes W, Cohen S: The genesis of lower esophageal sphincter pressure. Its identification through the use of gastrin antiserum. J Clin Invest 51:522–529, 1972

    PubMed  Google Scholar 

  5. McGuigan JE: Immunochemical studies with synthetic human gastrin. Gastroenterology 54:1005–1011, 1968

    PubMed  Google Scholar 

  6. Townsend CM, Vyvial TM, Wood AJ, Remmers AR, Sarles HE, Canales CO, Beathard GA, Fish JC Muniz F, Levin WC, Ritzmann SE: Antihuman lymphocyte globulin. Texas Rep Biol Med 27:497–504, 1969

    Google Scholar 

  7. Janeway CA, Rosen FS: The gamma globulins. Therapeutic uses of gamma globulin. N Engl J Med 275:826–831, 1966

    PubMed  Google Scholar 

  8. Freda VJ, Gorman JG, Pollach W: Suppression of the primary Rh immune response with passive Rh IgG immunoglobulin. New Engl J Med 277:1022–1023, 1967

    PubMed  Google Scholar 

  9. Monaco AP, Wood ML, Russell PS: Some effects of purified heterozygous antihuman lymphocyte serum in man. Transplantation (Suppl) 5:1106–1114, 1967

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

A portion of this paper was presented to the Gastroenterology session of the American Federation for Clinical Research, Southern Section, January 25, 1973.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, W.S., Hughes, J.B. & Ritzmann, S.E. Therapy with gastrin antibody in the Zollinger-Ellison syndrome. Digest Dis Sci 21, 201–204 (1976). https://doi.org/10.1007/BF01095891

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01095891

Keywords

Navigation